Expert NetworkExpert InterviewINCY

Slingshot members are talking to an expert! The topic is:

Discussing the INCY's Opzelura Cream (Ruxolitinib) in treating atopic dermatitis with a prescriber

Executed on:Mar 15, 2022 1:00 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: Private Practice
  • Board-Certified dermatologist practicing cosmetic, medical, surgical and pediatric dermatology.
  • Treats 5 patients with DEB and 100 patients with atopic dermatitis each month.
  • Served as a sub-investigator for 10 randomized clinical drug trials for atopic dermatitis, psoriasis, systemic lupus erythematosus and cutaneous T-cell lymphoma; investigator for Dupixent’s Phase 2 AD trials.

Interview Goal

This conversation will focus on the recently approved JAK inhibitor cream for AD, Opzelura Cream (Ruxolitinib), and where it fits into a Dermatologist's treatment armamentarium.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.